Our research confirmed that SMCs contribute a significant role in the formation of AD, and successfully identified seven key genes that associated with extracellular matrix function in SMCs, namely ACTA2, IL6, CTGF, BGN, ITGA8, THBS1, and CDH5, providing us new therapeutic targets for treatment of AD. The gene discussed is ACTA2; the disease is Alzheimer disease.